Literature DB >> 9123330

Attenuation of ischemic liver injury by a non-selective endothelin receptor antagonist.

M B Jin1, Y Zhu, S Zhang, N Ishizaki, H Tanaka, V M Subbotin, R G Lee, T E Starzl, S Todo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9123330      PMCID： PMC2962408          DOI： 10.1016/s0041-1345(96)00582-9

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

1.  Cyclic hexapeptide endothelin receptor antagonists highly potent for both receptor subtypes ETA and ETB.

Authors:  T Kikuchi; T Ohtaki; A Kawata; T Imada; T Asami; Y Masuda; T Sugo; K Kusumoto; K Kubo; T Watanabe
Journal:  Biochem Biophys Res Commun       Date:  1994-05-16       Impact factor: 3.575

2.  Role of microcirculatory derangements in manifestation of portal triad cross-clamping-induced hepatic reperfusion injury.

Authors:  B Vollmar; J Glasz; S Post; M D Menger
Journal:  J Surg Res       Date:  1996-01       Impact factor: 2.192

Review 3.  Hepatic lipocytes: a major target for endothelin-1.

Authors:  C N Housset; D C Rockey; S L Friedman; D M Bissell
Journal:  J Hepatol       Date:  1995       Impact factor: 25.083
  3 in total
  1 in total

1.  Effects of silibinin on hepatic warm ischemia-reperfusion injury in the rat model.

Authors:  Vahid Akbari-Kordkheyli; Soheil Azizi; Abbas Khonakdar-Tarsi
Journal:  Iran J Basic Med Sci       Date:  2019-07       Impact factor: 2.699
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.